Cargando…
Naringin protects myocardial cells from doxorubicin-induced apoptosis partially by inhibiting the p38MAPK pathway
Doxorubicin (DOX) has been widely used to treat cancers as a first-line antitumor drug. However, it causes severe, irreversible, dose-dependent cardiotoxicity. To evaluate the protective effects of naringin (NRG) on cardiotoxicity, the authors investigated the molecular mechanism of the p38MAPK sign...
Autores principales: | Jian, Chun-Yan, Ouyang, Han-Bin, Xiang, Xian-Hong, Chen, Jia-Li, Li, Yong-Xin, Zhou, Xin, Wang, Jin-Yang, Yang, Yang, Zhong, En-Yi, Huang, Wen-Hua, Zhang, Hong-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780003/ https://www.ncbi.nlm.nih.gov/pubmed/29152646 http://dx.doi.org/10.3892/mmr.2017.7823 |
Ejemplares similares
-
Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1
por: Zhao, Zirui, et al.
Publicado: (2022) -
Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway
por: Chen, Lingxia, et al.
Publicado: (2023) -
Ghrelin Protects against Dexamethasone-Induced INS-1 Cell Apoptosis via ERK and p38MAPK Signaling
por: Zhang, Chengshuo, et al.
Publicado: (2016) -
Protective Effects of Naringin in Cerebral Infarction and Its Molecular Mechanism
por: Yang, Jinping, et al.
Publicado: (2020) -
Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway
por: Zhao, Hui, et al.
Publicado: (2020)